Early initiation of gonadotropin-releasing hormone (GnRH) antagonist during assisted reproductive technology (ART)

Not Applicable

Completed

• Conditions: Polycystic ovarian syndrome; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN53514546
• Lead Sponsor: Hurley Medical Center (USA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-08-26
• Last Update Posted: 27 February 2017

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 140

Inclusion Criteria

1. Women (age between 18-40 years) with PCOS, undergoing assisted reproductive technology (ART). PCOS was defined according to Rotterdam criteria at least 2 of the following 3 features:
1.1. Oligo and/or anovulation
1.2. Clinical and/or biochemical signs of hyperandrogenism and
1.3. Polycystic ovary on ultrasound scan (The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group 2004)

Exclusion Criteria

1. Hypothyroidism
2. Hyperprolactinemia
3. Non-classical form of congenital adrenal hyperplasia
4. Cushing?s syndrome
5. Androgen-secreting tumors

Study & Design

• Study Type: Interventional
• Study Design: Not specified